Hepatitis a among Persons with Hemophilia Who Received Clotting Factor Concentrate - United States, September-December 1995

Morbidity and Mortality Weekly Report

Volumn 45, Issue 2, 1996, Pages 29-32

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CHILD; DISEASE TRANSMISSION; DRUG CONTAMINATION; FEMALE; HEMOPHILIA A; HEPATITIS A; HUMAN; MALE; UNITED STATES; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; CHILD; DRUG CONTAMINATION; FACTOR IX; FACTOR VIII; FEMALE; HEMOPHILIA A; HEPATITIS A; HUMANS; MALE; UNITED STATES; VON WILLEBRAND DISEASE;

EID: 0030592999     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mannucci PM, Santagostino E, Di Bona E, et al. The outbreak of hepatitis A in Italian patients with hemophilia: facts and fancies. Vox Sang 1994;67(suppl 1):31-5.
2. Brackmann H-H, Oldenburg J, Eis-Hubinger AM, Gerritzen A, Hammerstein U, Hanfland P. Hepatitis A virus infection among the hemophilia population at the Bonn Hemophilia Center. Vox Sang 1994;67(suppl 1):3-8.
3. Lawlor E, Johnson Z, Thornton L, Temperley I. Investigation of an outbreak of hepatitis A in Irish haemophilia A patients. Vox Sang 1994;67(suppl 1):18-20.
4. Peerlinck K, Goubau P, Coppens G, Desmyter J, Vermylen J. Is the apparent outbreak of hepatitis A in Belgian hemophiliacs due to a loss of previous passive immunity? Vox Sang 1994;67(suppl 1):14-7.
5. Mannucci PM, Gdovin S, Gringeri A, et al. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. Ann Intern Med 1994;120:1-7.
6. Robertson BH, Hkanna B, Nainan OV, Margolis HS. Epidemiologic patterns of wild-type hepatitis A virus determined by genetic variation. J Infect Dis 1991;163:286-92.
7. Lemon SM. The natural history of hepatitis A: the potential for transmission by transfusion of blood or blood products. Vox Sang 1994;67(suppl 4):19-23.
8. Normann A, Graff J, Gerritzen A, Brackmann H, Flehmig B. Detection of hepatitis A virus RNA in commercially available factor VIII preparation [Letter]. Lancet 1992;340:1232.
9. Schwinn H, Smith A, Wolter D. Progress in purification of virus-inactivated factor VIII concentrates. Drug Res 1989;39:1302.
10. Van Damme P, Thoelen S, Cramm M, De Groote K, Safary A, Meheus A. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. J Med Virol 1994;44:446-51.